Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
Novartis AG
Medicare publishes prices for the first 10 drugs subject to negotiations
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
Pharmaceutical companies negotiate new prices with Medicare
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris…
First round of Medicare drug price negotiations nearing end
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
This promising cancer treatment could represent a $25 billion market opportunity
Skynesher | E+ | fake images Big Pharma is betting billions on a promising class of cancer treatments that some…
Stocks set to move as this corner of the cancer therapy market heats up
Much attention has been paid lately to a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy…
FTC Challenges Drug Makers' Patents, Including Ozempic's
A box of Ozempic and its contents on a table in Dudley, North Tyneside, Britain, on October 31, 2023. Lee…
GRANOLAS Stock Drives Europe to Record Highs, Drawing Magnificent 7 Comparisons
The chart of the German stock price index DAX is displayed on the stock exchange in Frankfurt, Germany, on January…
GRANOLAS Stock Drives Europe to Record Highs, Drawing Magnificent 7 Comparisons
The chart of the German stock price index DAX is displayed on the stock exchange in Frankfurt, Germany, on January…